Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $112.20 | Total: $561.00 |
| 1 | 10 | $95.04 | Total: $950.40 |
| 1 | 25 | $80.52 | Total: $2,013.00 |
| 1 | 50 | $68.64 | Total: $3,432.00 |
| 1 | 100 | $59.40 | Total: $5,940.00 |
Overview
ACY-1083 is a selective, brain-penetrating HDAC6 inhibitor (IC50: 3 nM) that effectively reverses chemotherapy-induced peripheral neuropathy.
Chemical Properties
| Molecular Formula | C17H18F2N4O2 |
| Molecular Weight | 348.35 |
| CAS Numbers | 1708113-43-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | ONC(=O)c1cnc(NC2(CCC(F)(F)CC2)c2ccccc2)nc1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Krukowski K, et al. HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy. Pain. 2017 Jun;158[6] 1126-1137.